Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brownell

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Supervisory Management|November 7, 1982
Increasing your credibilityJ Brownell
ANS. Advances in Nursing Science|July 1, 1984
The concept of crisis: its utility for nursingM J Brownell
Children & Society|August 9, 2022
'COVID taught me…': Examining child-radio productions in the COVID-19 pandemicCassie J Brownell
Biochemical and Biophysical Research Communications|May 16, 1990
Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomerR Vince, J Brownell
Life Sciences|January 1, 1988
Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist propertiesR C Gaillard, J Brownell
Hormone Research|January 1, 1979
Prolactin. I. Mechanisms of control, peripheral actions and modification by drugsE del Pozo, J Brownell
Acta Endocrinologica|November 1, 1988
Hormonal effects of CQP 201-403, a new dopamine agonistR C Gaillard, J Brownell
Journal of Medicinal Chemistry|November 1, 1986
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesisR Vince, S Daluge, J Brownell
Journal of Medicinal Chemistry|October 1, 1984
Carbocyclic analogues of xylofuranosylpurine nucleosides. Synthesis and antitumor activityR Vince, J Brownell, S Daluge
Acta Endocrinologica|August 1, 1991
Clinical response and prolactin concentration in hyperprolactinemic women during and after treatment for 24 months with the new dopamine agonist, CV 205-502C Rasmussen, J Brownell, T Bergh
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Supervisory Management|November 7, 1982
Increasing your credibilityJ Brownell
ANS. Advances in Nursing Science|July 1, 1984
The concept of crisis: its utility for nursingM J Brownell
Children & Society|August 9, 2022
'COVID taught me…': Examining child-radio productions in the COVID-19 pandemicCassie J Brownell
Biochemical and Biophysical Research Communications|May 16, 1990
Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomerR Vince, J Brownell
Life Sciences|January 1, 1988
Hormonal effects of CV 205-502, a novel octahydrobenzo [g] quinoline with potent dopamine agonist propertiesR C Gaillard, J Brownell
Hormone Research|January 1, 1979
Prolactin. I. Mechanisms of control, peripheral actions and modification by drugsE del Pozo, J Brownell
Acta Endocrinologica|November 1, 1988
Hormonal effects of CQP 201-403, a new dopamine agonistR C Gaillard, J Brownell
Journal of Medicinal Chemistry|November 1, 1986
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesisR Vince, S Daluge, J Brownell
Journal of Medicinal Chemistry|October 1, 1984
Carbocyclic analogues of xylofuranosylpurine nucleosides. Synthesis and antitumor activityR Vince, J Brownell, S Daluge
Acta Endocrinologica|August 1, 1991
Clinical response and prolactin concentration in hyperprolactinemic women during and after treatment for 24 months with the new dopamine agonist, CV 205-502C Rasmussen, J Brownell, T Bergh
Pageof 5